Veristat LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Veristat LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10633
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers services such as clinical project management, data management, clinical monitoring, biostatistics, medical writing, project management, regulatory submissions-FDA representation, CDISC implementation, and statistical and strategic consulting services. It also helps its clients to analyze, design, execute, standardize, and report clinical studies, among others. Veristat supports study phases in all therapeutic areas for medical products. The company serves organizations that develop biological products, vaccines, medical devices, diagnostics agents, immune therapies and gene therapies, among others. Veristat is headquartered in Southborough, Massachusetts, the US.

Veristat LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veristat LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veristat LLC, Medical Devices Deals, 2012 to YTD 2018 9
Veristat LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Veristat LLC, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Variance Development Partners Invests In Veristat, Clinical Research Organization 11
Partnerships 12
Hemostemix Enters into Agreement with Topstone Research 12
Veristat Enters into Partnership with Cidara Therapeutics 13
Veristat Extends Partnership with EndoCeutics 14
Molecular Templates Enters into Agreement with Veristat 15
Veristat Enters into Agreement with Karyopharm Therapeutics 16
Veristat Partners with Multi-Regional Clinical Trials Center 17
Certara Partners with Veristat 18
Acquisition 19
Veristat Acquires Topstone Research 19
Veristat Acquires Spero Oncology 20
Veristat LLC – Key Competitors 21
Veristat LLC – Key Employees 22
Veristat LLC – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Veristat LLC, Pharmaceuticals & Healthcare, Key Facts 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veristat LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veristat LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Veristat LLC, Medical Devices Deals, 2012 to YTD 2018 9
Veristat LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Variance Development Partners Invests In Veristat, Clinical Research Organization 11
Hemostemix Enters into Agreement with Topstone Research 12
Veristat Enters into Partnership with Cidara Therapeutics 13
Veristat Extends Partnership with EndoCeutics 14
Molecular Templates Enters into Agreement with Veristat 15
Veristat Enters into Agreement with Karyopharm Therapeutics 16
Veristat Partners with Multi-Regional Clinical Trials Center 17
Certara Partners with Veristat 18
Veristat Acquires Topstone Research 19
Veristat Acquires Spero Oncology 20
Veristat LLC, Key Competitors 21
Veristat LLC, Key Employees 22
Veristat LLC, Other Locations 23
Veristat LLC, Subsidiaries 23

List of Figures
Veristat LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veristat LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veristat LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Veristat LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Touchstone Group Ltd:企業の戦略的SWOT分析
    Touchstone Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • China Digital Culture (Group) Limited (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Limited (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • J.K. Cement Ltd (JKCEMENT):企業の財務・戦略的SWOT分析
    J.K. Cement Ltd (JKCEMENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • Aderans Co Ltd:企業の戦略・SWOT・財務情報
    Aderans Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Aderans Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Calix, Inc. (CALX):企業の財務・戦略的SWOT分析
    Calix, Inc. (CALX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TAS Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary TAS Energy, Inc. (TAS), formerly Turbine Air Systems, Ltd., offers clean and modular energy solutions. The company designs, manufactures and supplies turbine inlet chilling systems for power augmentation; modular utility systems for air cooling; waste heat/geothermal systems for power genera …
  • iCubate Inc:企業の製品パイプライン分析
    Summary iCubate Inc (iCubate) is a molecular diagnostic company that provides molecular diagnostic and in vitro diagnostic testing devices for syndromic testing. It develops cassettes and assays. The company’s pipeline products include flu typing cassette; HAI cassette; and STD cassette. iCubate uti …
  • Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East Eng …
  • Oragenics Inc (OGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • Energias de Portugal SA:企業の発電所・SWOT分析2018
    Energias de Portugal SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Nichi-Iko Pharmaceutical Co Ltd (4541):製薬・医療:M&Aディール及び事業提携情報
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahis …
  • Harvard Medical School-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers prog …
  • Mentor Graphics Corporation:企業のM&A・事業提携・投資動向
    Mentor Graphics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mentor Graphics Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Santander Private Bank:企業の戦略・SWOT・財務分析
    Santander Private Bank - Strategy, SWOT and Corporate Finance Report Summary Santander Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Islet Sciences Inc (ISLT):企業の財務・戦略的SWOT分析
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Takuma Co Ltd (6013):企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆